http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2008001881-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
filingDate 2008-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d90962168276c9fe6e380032bfed0e8
publicationDate 2008-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2008001881-A1
titleOfInvention PHARMACEUTICAL COMPOSITION THAT INCLUDES IBUPROFEN AND A SELECTED ANTIHISTAMINIC OF ASTEMIZOL, AZATIDINE, AZELASTINE, ACRIVASTINE, BROMFENIRAMINE, CHLORFENIRAMINE, CLEMASTINE, AMONG OTHERS AND THAT DOES NOT INCLUDE A DESCONGESTION; PR PROCEDURE
priorityDate 2004-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502369
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284514
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553019
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536533
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2247
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19861
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504530

Total number of triples: 24.